8th Annual Hematology and Medical Oncology Board Review: Contemporary Practice


8th Annual Hematology and Medical Oncology Board Review: Contemporary Practice Banner



Date & Location
Friday, March 6, 2020, 7:30 AM - Monday, March 9, 2020, 12:00 PM, Zuckerman Research Center, 417 East 68th Street

Specialties
Specialties - Hematology, Medical Oncology, Oncology and Hematology

Overview
 

The 2020 Hematology and Medical Oncology Board Review Course is now available online (enduring) for purchase. Registered participants will be able to login and watch at their own pace and claim both CME and ABIM MOC credit after completion.

For more information, click here.

 

This four day course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology.  

The target audience for this course is medical oncology professionals, including physicians, nurses, pharmacists, fellows and residents.

Course registration includes access to an online syllabus (with downloadable PDF files and video clips of the presentations) as well as a USB flash drive.

Live Simulcast Available*

We are pleased to offer a live simulcast for this course. CME and ABIM MOC credit is offered for the live simulcast and active participation is required throughout the course. We do hope you will attend in person but understand that can sometimes be a challenge, so we are happy to offer the live simulcast as an option. Registration for the simulcast is required; please select the "Live Simulcast" option during course registration. A link to view the Symposium will be emailed to you the day before the course begins.


Objectives

By attending this course, attendees will:


  1. Learn state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers
  2. Learn state-of-the-science in diagnosis, staging, and therapeutic management of hematologic cancers
  3. Understand recent treatment advances in solid tumor and hematologic oncology and their impact on modern clinical practice

Registration

 Registration Fees
 Physicians (MDs, PhDs, and DOs)  $1,500 
 Residents, Fellows, Nurses, and Other Healthcare Providers    $975 
 Industry Professionals*  $2,625 
 Live Simulcast**    $1,700 

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.
**Please note that the live simulcast is only available to non-MSK employees. MSK employees are welcome to register to attend this course in person.

Course registration includes access to an online syllabus (with downloadable PDF files and video clips of the presentations), a USB flash drive, as well as continental breakfast, lunch, and refreshment breaks. Please contact cme@mskcc.org at least one week prior to the course if you have any special dietary requests or require any specific accommodations.

Registration Discounts/Promotions

  • MSK CME offers a discounted rate for MSK Alumni, MSK Cancer Alliance and Cancer Care Partners. If you are a member of one of these groups, please contact cme@mskcc.org for more information.
  • MSK employee registration is complimentary. However, you must complete course registration in order to attend this course. If you are registered for this course and are unable to attend, please email cme@mskcc.org. 

Please note that after your payment has been processed, no further promotional discount adjustments will be made to your registration.

Cancellation Policy

Live Simulcast registrations are non-refundable. For all other orders, if you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course (cme@mskcc.org). 

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information. 


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 32.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 32.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


--

*The live broadcast is for streaming use only. By watching the Simulcast you acknowledge that Memorial Sloan Kettering Cancer Center retains all rights, titles and interest in to all copyrights, trademarks, trade secrets, patents and any other proprietary rights to the content of the material. You are not authorized to record the event. You agree to prevent any unauthorized copying, recording, use, distribution and/or re-broadcast of this live simulcast.


Keywords: